These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 639169)

  • 1. Dissolution profile and bioavailability of sulfamonomethoxine/18-crown-6 complex in comparison with sulfamonomethoxine anhydrate and hydrate.
    Takayama K; Hasegawa S; Sasagawa S; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1978 Jan; 26(1):96-100. PubMed ID: 639169
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetics of sulfamonomethoxine combined with ultraviolet irradiation in acute pneumonia].
    Matveeva SA
    Ter Arkh; 1979; 51(11):114-8. PubMed ID: 524278
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose-dependent pharmacokinetics of intravenous sulfamonomethoxine in pigs.
    Shimoda M; Tsuboi T; Kokue E; Hayama T
    Jpn J Pharmacol; 1983 Aug; 33(4):903-5. PubMed ID: 6632387
    [No Abstract]   [Full Text] [Related]  

  • 4. Possibility of saturation in renal excretion after high dose of intravenous sulfamonomethoxine in pigs.
    Shimoda M; Shimizu T; Kokue E; Hayama T
    Nihon Juigaku Zasshi; 1984 Jun; 46(3):331-7. PubMed ID: 6482127
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of ascorbic acid on the absorption and acetylation of sulfamonomethoxine in the rat intestine].
    Makarov VA; Oldyreva LA
    Farmatsiia; 1980; 29(3):67-8. PubMed ID: 7409227
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma concentrations, plasma protein binding and residues of sulfamonomethoxine in pigs, horses and cattle.
    Rauws AG; van Schothorst M; Frik JF
    Tijdschr Diergeneeskd; 1975 Oct; 100(20):1099-104. PubMed ID: 1198573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood kinetics of sulfamonomethoxine and oxytetracycline following intrauterine spray injection in dairy cows.
    Girardi C; Re G; Farca AM; Dacasto M; Ferrero E; Eandi M
    Pharmacol Res; 1990; 22(2):79-86. PubMed ID: 2330344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of renal active secretion in renal excretion of N4-acetylsulfamonomethoxine in conscious pigs.
    Shimoda M; Kokue E; Tanaka N; Hayama T
    J Pharmacobiodyn; 1986 Nov; 9(11):865-70. PubMed ID: 3559878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining sulfamonomethoxine and its acetyl/hydroxyl metabolites in chicken plasma under organic solvent-free conditions.
    Furusawa N
    Anal Bioanal Chem; 2006 Aug; 385(8):1570-4. PubMed ID: 16838157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acetylation of sulfanilamide substances in toxic lesions of the liver].
    Makarov VA; Rekkandt SA; Leont'eva TP; Bondarenko OL
    Farmakol Toksikol; 1984; 47(5):60-3. PubMed ID: 6500037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic analysis of plasma concentration and urinary excretion of sulphamonomethoxine and its metabolite in Goettingen minipigs.
    Tsuboi T; Kokue E; Shimoda M; Hayama T
    J Vet Pharmacol Ther; 1984 Sep; 7(3):219-23. PubMed ID: 6492249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sulfanilamide absorption and acetylation in rats with experimental hyperlipidemia and cellular regulation of the process of acetylation].
    Makarov VA; Vasilenko IuK; Suetina IV; Vaskanian VL; Lubiankina SV
    Farmakol Toksikol; 1981; 44(1):109-15. PubMed ID: 6266869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of deacetylation in the nonlinear pharmacokinetics of sulfamonomethoxine in pigs.
    Shimoda M; Kokue E; Shimizu T; Muraoka R; Hayama T
    J Pharmacobiodyn; 1988 Aug; 11(8):576-82. PubMed ID: 3236216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined use of sulfamonomethoxine and UV irradiation in chronic pneumonia].
    Matveeva SA
    Sov Med; 1981; (12):85-7. PubMed ID: 7336270
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sulfadimezine and sulfamomomethoxine distribution in the body of white rats in single and repeated administration in combination with UV irradiation].
    Matveeva SA
    Farmakol Toksikol; 1979; 42(3):288-91. PubMed ID: 446714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of sulfamonomethoxine and ite N-methylglucamine salt in rats].
    Kivman GIa; Geĭtman IIa; Neugodova NP
    Farmakol Toksikol; 1977; 40(4):471-5. PubMed ID: 902752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Human pharmacokinetic characteristics of sulfamonomethoxine depending on the drug form].
    Geĭtman IIa; Neugodova NP; Tseĭtlin NN; Kivman GIa
    Farmakol Toksikol; 1979; 42(5):534-7. PubMed ID: 488331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent oral toxicity of 18-crown-6 in dogs.
    Takayama K; Hasegawa S; Sasagawa S; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1977 Nov; 25(11):3125. PubMed ID: 603970
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative evaluation of the therapeutic efficacy of sulfanilamides as a function of their pharmacokinetics in patients with infectious-inflammatory respiratory diseases].
    Matveeva SA
    Sov Med; 1981; (11):15-7. PubMed ID: 7336235
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of binding sites for sulfadimethoxine and its major metabolite, N4-acetylsulfadimethoxine, on human and rabbit serum albumin.
    Otagiri M; Nakamura H; Maruyama T; Imamura Y; Takadate A
    Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):498-501. PubMed ID: 2743500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.